Xiaofeng Yang Selected Research

Apolipoproteins E (ApoE)

1/2021	Adaptive Immune Response Signaling Is Suppressed in Ly6Chigh Monocyte but Upregulated in Monocyte Subsets of ApoE-/- Mice - Functional Implication in Atherosclerosis.
1/2020	Interleukin 35 Delays Hindlimb Ischemia-Induced Angiogenesis Through Regulating ROS-Extracellular Matrix but Spares Later Regenerative Angiogenesis.
1/2020	A Novel Subset of CD95+ Pro-Inflammatory Macrophages Overcome miR155 Deficiency and May Serve as a Switch From Metabolically Healthy Obesity to Metabolically Unhealthy Obesity.
1/2018	GATA3, HDAC6, and BCL6 Regulate FOXP3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg.
1/2018	IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14).
8/2017	SIRT1 inhibition promotes atherosclerosis through impaired autophagy.
11/2009	Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice.
9/2006	Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaofeng Yang Research Topics

Disease

91	Neoplasms (Cancer) 11/2022 - 01/2004
45	Inflammation (Inflammations) 01/2022 - 07/2012
22	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 02/2014
21	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2007
13	Infections 04/2022 - 03/2002
13	Atherosclerosis 01/2022 - 09/2006
12	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 08/2013
10	Asthma (Bronchial Asthma) 01/2021 - 09/2011
10	Hyperhomocysteinemia 01/2018 - 09/2006
9	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 05/2008
8	Epilepsy (Aura) 01/2022 - 01/2012
8	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 10/2017
8	Metabolic Diseases (Metabolic Disease) 01/2021 - 11/2016
8	Acute Lung Injury 03/2018 - 01/2012
8	Xerostomia 02/2018 - 09/2012
7	Fibrosis (Cirrhosis) 01/2022 - 02/2013
7	Hyperlipidemias (Hyperlipidemia) 01/2021 - 11/2009
7	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2003
7	Respiratory Hypersensitivity 06/2016 - 01/2012
6	Non-Muscle Invasive Bladder Neoplasms 03/2022 - 07/2016
6	Wounds and Injuries (Trauma) 01/2022 - 05/2008
6	Chronic Renal Insufficiency 01/2022 - 11/2016
6	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 09/2012
5	Carcinogenesis 11/2022 - 05/2003
5	Ovarian Neoplasms (Ovarian Cancer) 04/2022 - 07/2017
5	COVID-19 01/2022 - 12/2020
5	Ischemia 10/2021 - 01/2017
5	Reperfusion Injury 10/2021 - 03/2015
5	Neoplasm Metastasis (Metastasis) 08/2021 - 07/2017
5	Nasopharyngeal Carcinoma 02/2018 - 11/2016
5	Hypoxia (Hypoxemia) 01/2018 - 08/2013
4	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022 - 07/2016
4	Seizures (Absence Seizure) 12/2020 - 01/2012
4	Thrombosis (Thrombus) 10/2020 - 01/2017
4	Carcinoma (Carcinomatosis) 01/2019 - 05/2014
3	Liver Neoplasms (Liver Cancer) 11/2022 - 12/2019
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2021
3	Necrosis 01/2022 - 01/2021
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 05/2021 - 10/2019
3	Lymphoma (Lymphomas) 01/2021 - 08/2014

Drug/Important Bio-Agent (IBA)

36	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2006
22	CytokinesIBA 01/2022 - 01/2012
18	EnzymesIBA 02/2022 - 01/2010
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2014
11	Pharmaceutical PreparationsIBA 04/2022 - 01/2007
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2016
10	InflammasomesIBA 01/2021 - 01/2016
9	Messenger RNA (mRNA)IBA 08/2021 - 01/2012
8	Apolipoproteins E (ApoE)IBA 01/2021 - 09/2006
7	oxidized low density lipoproteinIBA 01/2022 - 11/2016
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2002
7	Complement System Proteins (Complement)IBA 10/2021 - 08/2014
7	Protons (Proton)IBA 01/2021 - 01/2016
6	Caspase 1 (ICE Protease)IBA 01/2022 - 01/2016
6	LipidsIBA 01/2022 - 11/2016
6	AntibodiesIBA 10/2021 - 02/2006
6	InterleukinsIBA 01/2021 - 11/2013
6	LipopolysaccharidesIBA 01/2021 - 10/2012
6	Sirtuin 1IBA 08/2017 - 01/2015
5	Indicators and Reagents (Reagents)IBA 11/2022 - 05/2009
5	ChemokinesIBA 08/2021 - 01/2012
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2012
5	Mitogen-Activated Protein KinasesIBA 01/2021 - 09/2011
5	Therapeutic UsesIBA 03/2020 - 05/2008
5	ApolipoproteinsIBA 01/2018 - 09/2006
5	OvalbuminIBA 06/2015 - 01/2012
4	HomocysteineIBA 01/2022 - 01/2007
4	AntigensIBA 01/2022 - 02/2006
4	InterferonsIBA 01/2022 - 01/2021
4	CaspasesIBA 01/2022 - 10/2020
4	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2020
4	Immunoglobulin M (IgM)IBA 10/2021 - 03/2015
4	Phosphotransferases (Kinase)IBA 01/2021 - 07/2017
4	AntioxidantsIBA 01/2021 - 01/2016
4	Phosphates (Orthophosphate)IBA 01/2021 - 04/2012
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2017
4	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 11/2009
4	Immunoglobulin E (IgE)IBA 06/2016 - 01/2012
4	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 01/2014 - 09/2006
4	Methacholine Chloride (Methacholine)FDA Link 12/2013 - 01/2012
3	Cisplatin (Platino)FDA LinkGeneric 11/2022 - 10/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2020
3	Biological ProductsIBA 01/2022 - 02/2016
3	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 05/2008
3	CholesterolIBA 05/2021 - 01/2020
3	NAD (NADH)IBA 01/2021 - 11/2015
3	Peptides (Polypeptides)IBA 01/2021 - 07/2016
3	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2019
3	ImmunosorbentsIBA 01/2021 - 04/2012
3	VaccinesIBA 01/2021 - 02/2009
3	ChromatinIBA 01/2021 - 11/2016

Therapy/Procedure

47	Radiotherapy 11/2022 - 09/2012
35	Therapeutics 03/2022 - 04/2006
10	Transplantation 01/2022 - 09/2008
6	Brachytherapy 11/2021 - 01/2014
4	Transurethral Resection of Bladder 03/2022 - 04/2020
4	Drug Therapy (Chemotherapy) 01/2021 - 10/2018
3	Decompressive Craniectomy 04/2022 - 08/2005